AFYA

Afya Ltd
NASDAQCONSUMER DEFENSIVEEDUCATION & TRAINING SERVICES

Key Statistics

Market Cap
$1.26B
P/E Ratio
8.31
EPS
$1.66
Beta
0.38
52W High
$16.16
52W Low
$12.45
50-Day MA
$14.24
200-Day MA
$14.48
Dividend Yield
4.74%
Profit Margin
20.40%
Forward P/E
7.13
PEG Ratio

About Afya Ltd

Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.83B
Gross Profit (TTM)$2.45B
EBITDA$1.49B
Operating Margin30.60%
Return on Equity16.70%
Return on Assets8.41%
Revenue/Share (TTM)$42.59
Book Value$10.62
Price-to-Book1.35
Price-to-Sales (TTM)0.33
EV/Revenue2.275
EV/EBITDA5.06
Quarterly Earnings Growth (YoY)17.60%
Quarterly Revenue Growth (YoY)5.70%
Shares Outstanding$52.88M
Float$5.74M
% Insiders73.80%
% Institutions18.97%

Historical Volatility

HV 10-Day
34.10%
HV 20-Day
29.80%
HV 30-Day
26.39%
HV 60-Day
25.34%
HV Rank
49.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($16.72 target)
1
Strong Buy
5
Hold
3
Sell

Latest News

Afya (AFYA) Q2 Earnings and Revenues Lag Estimates

Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago.

Zacks Investment Research8/14/2026Negative
Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolution set out in its Notice of Annual General Meeting dated June 2, 2026 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2025. About Afya Limited Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end p.

Business Wire6/22/2026Neutral
Are Investors Undervaluing Afya (AFYA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research6/15/2026Positive
AFYA vs. APEI: Which Stock Is the Better Value Option?

Investors interested in Schools stocks are likely familiar with Afya (AFYA) and American Public Education (APEI). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research6/11/2026Neutral
Should Value Investors Buy Afya (AFYA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research5/28/2026Positive
AFYA or APEI: Which Is the Better Value Stock Right Now?

Investors with an interest in Schools stocks have likely encountered both Afya (AFYA) and American Public Education (APEI). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research5/20/2026Positive
Are Investors Undervaluing Afya (AFYA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research5/11/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AFYA and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

Data last updated: 8/18/2026